Recombinant Human Bone Morphogenetic Protein-2 Loaded Acellular Dermal Matrix in Horizontal Ridge Augmentation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Horizontal ridge deficiency in the posterior mandible often necessitates augmentation to achieve optimal implant placement and ensure long-term functional success. Although recombinant human bone morphogenetic protein-2 (rhBMP-2) and acellular dermal matrix (ADM) have individually been explored for bone regeneration, their combined clinical use—especially under functional loading—remains limited. This report presents two clinical cases involving horizontal ridge augmentation using rhBMP-2-loaded ADM without the use of additional grafting material. Radiographic evaluations at 5–6 months postoperatively confirmed horizontal bone gains of 1.5 mm and 1.7 mm, respectively. The newly formed bone was continuous with the adjacent native bone and fully covered the previously exposed implant threads. No postoperative complications, including peri-implantitis or peri-implant mucositis, were observed during the 13- and 10-month follow-up periods.
Abstract
Horizontal ridge deficiency in the posterior mandible often necessitates augmentation to achieve optimal implant placement and ensure long-term functional success. Although recombinant human bone morphogenetic protein-2 (rhBMP-2) and acellular dermal matrix (ADM) have individually been explored for bone regeneration, their combined clinical use—especially under functional loading—remains limited. This report presents two clinical cases involving horizontal ridge augmentation using rhBMP-2-loaded ADM without the use of additional grafting material. Radiographic evaluations at 5–6 months postoperatively confirmed horizontal bone gains of 1.5 mm and 1.7 mm, respectively. The newly formed bone was continuous with the adjacent native bone and fully covered the previously exposed implant threads. No postoperative complications, including peri-implantitis or peri-implant mucositis, were observed during the 13- and 10-month follow-up periods.